KHTRF News and Press, Knight Therapeutics Inc From 08/13/21

Knight Therapeutics Inc. (KHTRF) Q2 2021 Earnings Conference Call August 13, 2021, 08:30 AM ET Company Participants Jonathan Ross Goodman - Chief Executive Officer Samira Sakhia - President, Chief Operating Officer and Director Amal Khouri - Chief Business Officer Arvind Utchanah - Chief Fina...

Summers Value Partners is a boutique value manager that uses a focused, long-term approach to investing in areas of the market where most managers are unwilling or unable to participate. The biggest contributor in the second quarter was Inotiv (NOTV), which appreciated by 33% and was ...

Knight Therapeutics (KHTRF) announces that Health Canada has approved Nerlynx (neratinib) in combination with capecitabine for the treatment of adult patients with metastatic HER2-overexpressed/amplified breast cancer, who have received two or more prior anti-HER2-based regimens.The approval ...

Knight Therapeutics Inc. (KHTRF) Q1 2021 Earnings Conference Call May 14, 2021 8:30 AM ET Company Participants Jonathan Ross Goodman - Chief Executive Officer Samira Sakhia - President, Chief Operating Officer and Director Amal Khouri - Chief Business Officer Arvind Utchanah - Chief Financial...

Knight Therapeutics (KHTRF) has appointed Samira Sakhia as its new president and chief executive officer effective September 1, 2021.Ms. Sakhia currently serves as the company’s president and chief operating officer. The current chairman of the Board, James Gales will take up...

Summers Value Partners is a boutique value manager that uses a focused, long-term approach to investing in areas of the market where most managers are unwilling or unable to participate. The Summers Value Fund LP returned 17.5% net during Q1’21, outpacing the Russell 2000 Index...

Knight Therapeutics Inc. (KHTRF) Q4 2020 Results Earnings Conference Call March 25, 2021, 08:30 AM ET Company Participants Jonathan Ross Goodman - Chief Executive Officer Samira Sakhia - President & Chief Operating Officer Amal Khouri - Chief Business Officer Arvind Utchanah - Chief Finan...

Knight Therapeutics Inc. (KHTRF) Q3 2020 Earnings Conference Call November 13, 2020 08:30 AM ET Company Participants Jonathan Ross Goodman - Chief Executive Officer Samira Sakhia - President & Chief Operating Officer Amal Khouri - Vice President, Business Development Arvind Utchanah - Chi...

Knight Therapeutics (KHTRF) and TherapeuticsMD (TXMD) announces approval of BIJUVA capsules by Health Canada. Knight and TherapeuticsMD signed a license agreement in July 2018 pursuant to which TherapeuticsMD granted Knight the exclusive Canadian commercialization rights t...

Health Canada approves TherapeuticsMD (NASDAQ: TXMD ) and Knight Therapeutics' ( OTC:KHTRF )  Imvexxy for the treatment of postmenopausal moderate to severe dyspareunia, a symptom of vulvar and vaginal atrophy (VVA). More news on: TherapeuticsMD, Inc., Knight Therapeutics In...